 Vancouver, British Columbia and Minneapolis, Minnesota--Newsfile Corp. - April 19, 2021 - Neovasc, Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company today announced that the journal EuroIntervention has published an article entitled, Coronary Sinus Reducer Implantation Results in Improved Oxygen Kinetics at Cardiopulmonary Exercise Test in Patients with Refractory Angina. The article, authored by Carlo Zivelonghi, M.D., Antwerp Cardiovascular Center, Antwerp, Belgium, describes objective improvements in effort tolerance and oxygen kinetics as assessed by... 